The dual role of miR-184 in cancer: a systematic review of context-dependent regulation

Duff, B orcid iconORCID: 0009-0007-9012-6131 and Swadi, R orcid iconORCID: 0000-0002-4016-622X (2025) The dual role of miR-184 in cancer: a systematic review of context-dependent regulation. Molecular Biology Reports, 53 (1). ISSN 0301-4851

[thumbnail of s11033-025-11314-4.pdf]
Preview
Text
s11033-025-11314-4.pdf - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview

Abstract

MicroRNA-184 (miR-184) regulates gene expression by binding to target messenger RNAs, promoting their degradation, and influencing key cellular processes. Its role in human cancers is complex: while several studies report tumour-suppressive effects, including inhibition of proliferation, migration, and metastasis, contradictory evidence indicates that miR-184 may act as a tumour promoter in certain contexts. This systematic review aimed to clarify whether miR-184 functions as a universal anticancer agent across human cancers. A comprehensive search of PubMed and SCOPUS identified 123 records, of which 55 studies met inclusion criteria. Analysis revealed that miR-184 predominantly acts as a tumour suppressor in cancers such as prostate and breast, whereas in liver and bone cancers, it exhibits tumour-promoting activity. Certain cancer types, including skin and pancreatic cancers, showed inconsistent or context-dependent effects. Key molecular targets and pathways influenced by miR-184, including c-MYC, caspases, and apoptotic signalling, were highlighted. Overall, these findings demonstrate that the function of miR-184 in cancer is context-dependent, shaped by tissue type, molecular environment, and cellular signalling networks.

Item Type: Article
Uncontrolled Keywords: 0601 Biochemistry and Cell Biology; Biochemistry & Molecular Biology; 3101 Biochemistry and cell biology
Subjects: Q Science > QD Chemistry
R Medicine > RS Pharmacy and materia medica
Divisions: Pharmacy and Biomolecular Sciences
Publisher: Springer Science and Business Media LLC
Date of acceptance: 24 November 2025
Date of first compliant Open Access: 12 December 2025
Date Deposited: 12 Dec 2025 14:01
Last Modified: 12 Dec 2025 14:01
DOI or ID number: 10.1007/s11033-025-11314-4
URI: https://researchonline.ljmu.ac.uk/id/eprint/27710
View Item View Item